Codrin I. Lungu MD
Program Director, Division of Clinical Research, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MarylandDr. Codrin Lungu is a board-certified neurologist specializing in movement disorders, with expertise in multiple aspects of clinical neurology.
Previously, Dr. Lungu had been the Chief of the NIH Parkinson clinic, which he led for over 5 years. He also established, in collaboration with the Surgical Neurology Branch, the first NIH Deep Brain Stimulation program, and has led the NIH Botulinum Toxin clinic for 8 years. His experience includes research in imaging biomarkers, neuromodulation, and early clinical trials of novel therapeutic agents.
In the current role, Dr. Lungu provides guidance and leadership for the development and implementation of clinical research, develops initiatives aimed and reducing neurological disease burden, and promotes and coordinates collaborative research in neurology and related fields. He serves as Project Officer and Project Scientist on studies in various stages, including large trial networks.
He also continues to be involved in clinical research and teaching activities in the NIH Clinical Center and the NIH Movement Disorders Fellowship Program.
Recent Contributions to PracticeUpdate:
- SARS-CoV-2 and the Risk of Parkinson's
- Neural Stimulation for Alzheimer's
- OGENTYS With Levodopa/Carbidopa to Reduce 'Off' Time in Parkinson's Disease
- Gene Therapy for Advanced Parkinson’s Disease
- A Multidisciplinary Care Model for Dystonia
- Joining Societies and Networking
- Finding Your First Job
- What Makes a Good Mentor?
- Survival and Dementia in Patients With GBA-Associated Parkinson's Disease
- Neuropathic Gaucher's Mutations Accelerate Cognitive Decline in Patients With Parkinson's Disease